Ad
related to: Moderna COVID-19 Vaccine (Spikevax)
Search results
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 4 days agoThe vaccine will be Moderna’s second product to enter the U.S. market after the FDA’s approval of...
Moderna wins second product approval with RSV vaccine
Market Watch· 4 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoCOVID vaccine, agency staff said in a briefing document released Monday. In the briefing document,...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 6 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 1,296 shares of the company’s stock in a transaction dated Tuesday, May 28th. Following the ...
FDA Approves First mRNA RSV Vaccine
MedPage Today· 5 days agoThe vaccine will be Moderna's second marketed product, in addition to its SARS-CoV-2 mRNA-1273 vaccine (Spikevax).
Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
BioresearchOnline· 7 days agoLipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and...
